{
      "Rank": 236,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Basic medication\uff1aAspirin Enteric-coated Tablets & Atorvastatin Calcium\uff1b Allogeneic umbilical cord mesenchymal stem cells",
            "Basic medication\uff1aAspirin Enteric-coated Tablets & Atorvastatin Calcium; Placebo\uff1asaline"
      ],
      "ArmGroupInterventionName": [
            "Biological: Allogeneic umbilical cord mesenchymal stem cell",
            "Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium",
            "Drug: Aspirin Enteric-coated Tablets & Atorvastatin Calcium"
      ],
      "ArmGroupLabel": [
            "Experimental group",
            "Control group"
      ],
      "ArmGroupType": [
            "Experimental",
            "Placebo Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT03176498"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This is a randomized, double-blind study. Human umbilical cord mesenchymal stem cells (hUC-MSC) will be treated on cerebral infarction patients, and evaluates their neurological function of convalescent period."
      ],
      "BriefTitle": [
            "Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife\u00ae-CI) for Cerebral Infarction Patients in Convalescent Period."
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "December 2023"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Cerebral Infarction"
      ],
      "ConditionAncestorId": [
            "D000007511",
            "D000010335",
            "D000009336",
            "D000020520",
            "D000002545",
            "D000002561",
            "D000001927",
            "D000002493",
            "D000009422",
            "D000020521",
            "D000014652",
            "D000002318"
      ],
      "ConditionAncestorTerm": [
            "Ischemia",
            "Pathologic Processes",
            "Necrosis",
            "Brain Infarction",
            "Brain Ischemia",
            "Cerebrovascular Disorders",
            "Brain Diseases",
            "Central Nervous System Diseases",
            "Nervous System Diseases",
            "Stroke",
            "Vascular Diseases",
            "Cardiovascular Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC23",
            "All",
            "BC10",
            "BC14"
      ],
      "ConditionBrowseBranchName": [
            "Symptoms and General Pathology",
            "All Conditions",
            "Nervous System Diseases",
            "Heart and Blood Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Infarction",
            "Cerebral Infarction"
      ],
      "ConditionBrowseLeafId": [
            "M9434",
            "M4945",
            "M9695",
            "M11436",
            "M21458",
            "M4946",
            "M4962",
            "M4356",
            "M4894",
            "M21459",
            "M16552"
      ],
      "ConditionBrowseLeafName": [
            "Infarction",
            "Cerebral Infarction",
            "Ischemia",
            "Necrosis",
            "Brain Infarction",
            "Brain Ischemia",
            "Cerebrovascular Disorders",
            "Brain Diseases",
            "Central Nervous System Diseases",
            "Stroke",
            "Vascular Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000002544",
            "D000007238"
      ],
      "ConditionMeshTerm": [
            "Cerebral Infarction",
            "Infarction"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "Double"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [
            "Participant",
            "Investigator"
      ],
      "DetailedDescription": [
            "40 participants will be selected based on eligibility criteria and collected information, then, randomly separated into two groups. All participants will sign informed consent form, monitor vital signs, laboratory examination (CT/MRI, blood routine examination, urine routine examination, liver function, renal function, etc.), NIHSS, Fugl-Meyer analysis (FMA) 0-3 days before treatment. All of them will receive basic treatment with Aspirin Enteric-coated Tablets and Atorvastatin Calcium. And experimental group will treat with hUC-MSC, control group with placebo (normal saline) on the 7th and 14th day. After the treatment, investigator will follow-up, monitor vital signs, laboratory examination, NIHSS, FMA analysis on 2 weeks, 1 month, and 6 months after the treatment."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nproved cerebral infarction by CT or MRI.\nno cerebrovascular disease before\nsigned informed consent form\n\nExclusion Criteria:\n\nserious body and intracranial lesions (tumor, infection, etc.)\npatients repeated cerebral infarction attacks\nmulti-foci of cerebral infarction\nhistory of drug dependence and mental disease\ndisturbance of consciousness and non-compliance patients\nsubjects who are HIV positive\npregnant or lactation\ndonor: HIV infected, Active hepatitis B/C infected, Syphilis antibody positive\nsubjects/ donor: alcoholism, drug addicts or mental disease"
      ],
      "EnrollmentCount": [
            "40"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000077264",
            "D000045505",
            "D000000894",
            "D000018712",
            "D000000700",
            "D000018689",
            "D000018373",
            "D000000893",
            "D000018501",
            "D000005343",
            "D000050299",
            "D000045504",
            "D000010975",
            "D000016861",
            "D000004791",
            "D000058633",
            "D000000924",
            "D000000960",
            "D000000963",
            "D000057847",
            "D000019161"
      ],
      "InterventionAncestorTerm": [
            "Calcium-Regulating Hormones and Agents",
            "Physiological Effects of Drugs",
            "Anti-Inflammatory Agents, Non-Steroidal",
            "Analgesics, Non-Narcotic",
            "Analgesics",
            "Sensory System Agents",
            "Peripheral Nervous System Agents",
            "Anti-Inflammatory Agents",
            "Antirheumatic Agents",
            "Fibrinolytic Agents",
            "Fibrin Modulating Agents",
            "Molecular Mechanisms of Pharmacological Action",
            "Platelet Aggregation Inhibitors",
            "Cyclooxygenase Inhibitors",
            "Enzyme Inhibitors",
            "Antipyretics",
            "Anticholesteremic Agents",
            "Hypolipidemic Agents",
            "Antimetabolites",
            "Lipid Regulating Agents",
            "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
      ],
      "InterventionArmGroupLabel": [
            "Experimental group",
            "Control group",
            "Experimental group"
      ],
      "InterventionBrowseBranchAbbrev": [
            "All",
            "Antipy",
            "Infl",
            "ARhu",
            "FiAg",
            "Analg",
            "PlAggInh",
            "Lipd",
            "BDCA"
      ],
      "InterventionBrowseBranchName": [
            "All Drugs and Chemicals",
            "Antipyretics",
            "Anti-Inflammatory Agents",
            "Antirheumatic Agents",
            "Fibrinolytic Agents",
            "Analgesics",
            "Platelet Aggregation Inhibitors",
            "Lipid Regulating Agents",
            "Bone Density Conservation Agents"
      ],
      "InterventionBrowseLeafAsFound": [
            "Diabetes",
            "Dietary Supplement",
            "THA"
      ],
      "InterventionBrowseLeafId": [
            "M4533",
            "M3700",
            "M351",
            "M4550",
            "M8941",
            "M3369",
            "M3370",
            "M3184",
            "M19939",
            "M19757",
            "M7625",
            "M13017",
            "M18361",
            "M28329",
            "M3395",
            "M3430",
            "M3433",
            "M28036",
            "M20308"
      ],
      "InterventionBrowseLeafName": [
            "Calcium",
            "Aspirin",
            "Atorvastatin",
            "Calcium, Dietary",
            "Hormones",
            "Anti-Inflammatory Agents",
            "Anti-Inflammatory Agents, Non-Steroidal",
            "Analgesics",
            "Analgesics, Non-Narcotic",
            "Antirheumatic Agents",
            "Fibrinolytic Agents",
            "Platelet Aggregation Inhibitors",
            "Cyclooxygenase Inhibitors",
            "Antipyretics",
            "Anticholesteremic Agents",
            "Hypolipidemic Agents",
            "Antimetabolites",
            "Lipid Regulating Agents",
            "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
      ],
      "InterventionBrowseLeafRelevance": [
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "Experimental group receive Allogeneic umbilical cord mesenchymal stem cell\uff0ci.v (SCLnow 19#)",
            "Aspirin Enteric-coated Tablets, 0.1g/d by mouth; Atorvastatin Calcium, 20mg/d by mouth."
      ],
      "InterventionMeshId": [
            "D000001241",
            "D000069059",
            "D000002118"
      ],
      "InterventionMeshTerm": [
            "Aspirin",
            "Atorvastatin",
            "Calcium"
      ],
      "InterventionName": [
            "Allogeneic umbilical cord mesenchymal stem cell",
            "Aspirin Enteric-coated Tablets & Atorvastatin Calcium"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological",
            "Drug"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "cerebral Infarction",
            "umbilical cord mesenchymal stem cells"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "May 9, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "May 5, 2022"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Sclnow Biotechnology Co., Ltd."
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Hohhot"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "China"
      ],
      "LocationFacility": [
            "Inner Mongolia International Mongolian Hospital"
      ],
      "LocationState": [
            "Inner Mongolia"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "010065"
      ],
      "MaximumAge": [
            "75 Years"
      ],
      "MinimumAge": [
            "20 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "The Effects of Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neurological Function for Cerebral Infarction Patients in Convalescent Period."
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Sclnow Biotechnology Co., Ltd."
      ],
      "OrgStudyId": [
            "SCLnow-IMIMH-01"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Inner Mongolia International Mongolian Hospital",
            "China-Japan Union Hospital, Jilin University"
      ],
      "OverallOfficialName": [
            "Wulan",
            "Lei Guo, Dr"
      ],
      "OverallOfficialRole": [
            "Study Director",
            "Study Chair"
      ],
      "OverallStatus": [
            "Suspended"
      ],
      "OversightHasDMC": [],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 2022"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Based on Activity of Daily Living Scale (ADL) to analysis efficacy of cell treatment.The score of patient with upper limb >60, and total score >90 is considered good recovery."
      ],
      "PrimaryOutcomeMeasure": [
            "Motor function analysis"
      ],
      "PrimaryOutcomeTimeFrame": [
            "6 months"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "According to Chinese scale of clinical neurologic deficit to analysis, the result as follow:\n\nExcellent: after treatment, patient with consciousness, and clinical symptoms improved;\nEffective: vital signs and main symptoms in remission;\nInefficient: no obvious improvement or condition worsened.",
            "Using fugl-meyer assessment evaluate motor function. Mild movement disorder: 96 - 99; Moderate movement disorder: 85 - 95; Obvious movement disorder: 50 - 84; Serious movement disorder: < 50",
            "Obvious effective: Barthel Index score between 96 - 99, patient with self care ability.\n\nEffective:Barthel Index score between 70 - 89, patient with condition improved. Invalid: The effect do not meet above standards."
      ],
      "SecondaryOutcomeMeasure": [
            "Neurological deficits analysis",
            "Limb motor function analysis",
            "Barthel Index analysis"
      ],
      "SecondaryOutcomeTimeFrame": [
            "6 months",
            "6 months",
            "6 months"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "June 2022"
      ],
      "StartDateType": [
            "Anticipated"
      ],
      "StatusVerifiedDate": [
            "January 2022"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "June 5, 2017"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "May 23, 2017"
      ],
      "StudyFirstSubmitQCDate": [
            "May 31, 2017"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": [
            "Others"
      ]
}